Apply medical judgment throughout the review process in partnership with Commercial, Regulatory, and Legal stakeholders\n \nField Medical Affairs & External Engagement\n\n Provide clinical leadership and scientific guidance to support field medical needs, including MSL training, scientific readiness, and participation in KOL interactions\n Depending on compound, lead and/or participate in advisory boards, investigator meetings, and scientific exchange activities in a compliant, non-promotional manner\n \nLead and oversee US medical research efforts\n\n Oversight of investigator sponsored research (ISR) and leading Phase 4 studies, from strategic planning to data readout\n Ensure studies address meaningful clinical and scientific questions, generate high-quality data, and align with overall medical and evidence-generation strategy\n \nPipeline & Early-Stage Assets\n\n Act as the Medical Affairs lead for early-stage pipeline programs (FcRn and TSHR asset)\n Provide medical input into development strategy, target product profiles, evidence needs, and external scientific positioning in close collaboration with cross-functional partners.\n This individual will help ensure our medical strategy is clinically meaningful, scientifically rigorous and shape evidence generation, scientific communications, and external engagement across the lifecycle of our therapies\u2014from early pipeline through launch and post-approval.